Literature DB >> 14615625

Smoking and risk of hemorrhagic stroke in women.

Tobias Kurth1, Carlos S Kase, Klaus Berger, J Michael Gaziano, Nancy R Cook, Julie E Buring.   

Abstract

BACKGROUND AND
PURPOSE: Several studies established smoking as a risk factor for ischemic stroke and subarachnoid hemorrhage (SAH) in men and women. A recent study added smoking as a risk factor for intracerebral hemorrhage (ICH) in men. In contrast, the impact of smoking on ICH in women is less clear.
METHODS: Prospective cohort study among 39 783 US women participating in the Women's Health Study. Smoking habits and stroke occurrence were self-reported. Stroke cases were confirmed by medical record review. We used Cox proportional hazards model to evaluate the association of smoking with risk of total hemorrhagic stroke, ICH, and SAH. We categorized smoking into never, past, and current smokers of <15 and >or=15 cigarettes per day.
RESULTS: During 9 years of follow up, a total of 70 hemorrhagic strokes occurred, of which 40 were ICH and 29 were SAH. Never smokers and past smokers had equal rates of ICH and SAH. Current smokers of <15 cigarettes per day had a multivariable-adjusted relative risk (RR) of 1.93 (95% CI, 0.75 to 5.02) for total hemorrhagic stroke, 2.15 (95% CI, 0.62 to 7.43) for ICH, and 1.70 (95% CI, 0.38 to 7.60) for SAH. Women who smoked >or=15 cigarettes per day had RR of 3.29 (95% CI, 1.72 to 6.29) for total hemorrhagic stroke, 2.67 (95% CI, 1.04 to 6.90) for ICH, and 4.02 (95% CI, 1.63 to 9.89) for SAH compared with never smokers.
CONCLUSIONS: This prospective study indicates an increased risk of total hemorrhagic stroke, ICH, and SAH in women who are current cigarette smokers. The risk increases with the amount of cigarettes smoked.

Entities:  

Mesh:

Year:  2003        PMID: 14615625     DOI: 10.1161/01.STR.0000100165.36466.95

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  33 in total

1.  [Recommendations of the European Stroke Initiative for the diagnosis and treatment of spontaneous intracerebral haemorrhage].

Authors:  S Külkens; P Ringleb; J Diedler; W Hacke; T Steiner
Journal:  Nervenarzt       Date:  2006-08       Impact factor: 1.214

2.  Effect of chronic obstructive pulmonary disease on swallowing function in stroke patients.

Authors:  Gun Woong Park; Suk Kyoung Kim; Chang Hwa Lee; Chung Reen Kim; Ho Joong Jeong; Dong Kyu Kim
Journal:  Ann Rehabil Med       Date:  2015-04-24

3.  Critical care management of acute intracerebral hemorrhage.

Authors:  Joshua N Goldstein; Aaron J Gilson
Journal:  Curr Treat Options Neurol       Date:  2011-04       Impact factor: 3.598

4.  BLEED-Myocardial Infarction Score: Predicting mid-term post-discharge bleeding events.

Authors:  Sérgio Barra; Rui Providência; Francisca Caetano; Inês Almeida; Luís Paiva; Paulo Dinis; António Leitão Marques
Journal:  World J Cardiol       Date:  2013-06-26

5.  Cigarette Smoking History and Functional Outcomes After Spontaneous Intracerebral Hemorrhage.

Authors:  Ching-Jen Chen; Dale Ding; Natasha Ironside; Thomas J Buell; Andrew M Southerland; Sebastian Koch; Matthew Flaherty; Daniel Woo; Bradford B Worrall
Journal:  Stroke       Date:  2019-03       Impact factor: 7.914

6.  Cryptogenic stroke-the appropriate diagnostic evaluation.

Authors:  Hardik Amin; David M Greer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-01

7.  Smoking cessation for the neurologic patient.

Authors:  Jinny Tavee
Journal:  Neurol Clin Pract       Date:  2012-06

8.  Healthy Lifestyle and Functional Outcomes from Stroke in Women.

Authors:  Pamela M Rist; Julie E Buring; Carlos S Kase; Tobias Kurth
Journal:  Am J Med       Date:  2016-02-18       Impact factor: 4.965

Review 9.  Stem cell therapy in intracerebral hemorrhage rat model.

Authors:  Marcos F Cordeiro; Ana P Horn
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

Review 10.  Intracerebral hemorrhage and hypertension.

Authors:  Maria Sessa
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.